Enigma Biomedical USA awarded a grant from The Michael J. Fox Foundation for Discovery and Development of Novel α-Synuclein PET Imaging Biomarker
KNOXVILLE, Tenn. — Enigma Biomedical USA (EB USA) today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF), has awarded EB USA $2 million for the discovery and initial preclinical development of a novel α-synuclein Positron Emission
(Financial Post, 2025-11-25T12:30:48Z)